Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Morphic Holding stock
Learn how to easily invest in Morphic Holding stock.
Morphic Holding Inc is a biotechnology business based in the US. Morphic Holding shares (MORF) are listed on the NASDAQ and all prices are listed in US Dollars. Morphic Holding employs 101 staff and has a trailing 12-month revenue of around $75.3 million.
How to buy shares in Morphic Holding
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MORF – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Morphic Holding stock price (NASDAQ: MORF)Use our graph to track the performance of MORF stocks over time.
Morphic Holding shares at a glance
|Latest market close||$28.30|
|52-week range||$19.23 - $68.75|
|50-day moving average||$28.64|
|200-day moving average||$33.77|
|Wall St. target price||$62.63|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.88|
Buy Morphic Holding shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Morphic Holding stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Morphic Holding price performance over time
|1 week (2022-09-23)||8.93%|
|1 month (2022-09-02)||-0.11%|
|3 months (2022-07-01)||27.31%|
|6 months (2022-04-01)||-32.13%|
|1 year (2021-10-01)||-47.55%|
|2 years (2020-10-02)||9.78%|
|3 years (2019-10-02)||62.08%|
|5 years (2017-09-28)||N/A|
Morphic Holding financials
|Revenue TTM||$75.3 million|
|Gross profit TTM||$-67,995,000|
|Return on assets TTM||-7.62%|
|Return on equity TTM||-13.88%|
|Market capitalisation||$971.2 million|
TTM: trailing 12 months
Morphic Holding share dividends
We're not expecting Morphic Holding to pay a dividend over the next 12 months.
Morphic Holding share price volatility
Over the last 12 months, Morphic Holding's shares have ranged in value from as little as $19.23 up to $68.75. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Morphic Holding's is 1.4592. This would suggest that Morphic Holding's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Morphic Holding overview
Morphic Holding, Inc. , a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; and preclinical trial to treat idiopathic pulmonary fibrosis and fibrosis diseases. The company is also developing avß6 for the treatment of fibrotic diseases, and avß8 to treat solid tumors, as well as various other products. Morphic Holding, Inc. has a research collaboration with Engitix Ltd for the identification of Morphic integrin technology amenable targets in fibrostenotic IBD; a collaboration agreement with Schrödinger, LLC for integrin targets; and a license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. It also has collaboration agreements with AbbVie Biotechnology Ltd and Janssen Pharmaceuticals, Inc.
Morphic Holding in the news
Sarepta (SRPT) Seeks FDA Nod for DMD Gene Therapy Candidate
Those who invested in Morphic Holding (NASDAQ:MORF) three years ago are up 66%
EMA Accepts Moderna's (MRNA) Filing for Omicron BA.4, BA.5 Booster
Frequently asked questionsWhat percentage of Morphic Holding is owned by insiders or institutions?
Currently 20.496% of Morphic Holding shares are held by insiders and 89.17% by institutions. How many people work for Morphic Holding?
Latest data suggests 101 work at Morphic Holding. When does the fiscal year end for Morphic Holding?
Morphic Holding's fiscal year ends in December. Where is Morphic Holding based?
Morphic Holding's address is: 35 Gatehouse Drive, A2, Waltham, MA, United States, 02451 What is Morphic Holding's ISIN number?
Morphic Holding's international securities identification number is: US61775R1059 What is Morphic Holding's CUSIP number?
Morphic Holding's Committee on Uniform Securities Identification Procedures number is: 61775R105
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert